Research sheds light on a novel disease mechanism in chronic smokers

(Biochemical Society) Research published in the journal Clinical Science suggests that an immune signalling protein called interleukin (IL)-26 is increased among chronic smokers with lung disease and this involvement reveals disease mechanisms of interest for developing more effective therapy for these hard-to-treat patients.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news